RG
RegeneRx Biopharmaceuticals, Inc.
RGRX · OTC
$0.00 +0.00% (+$0.00)
1M +57.14%
Market Cap $898.0
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/S 0.01x
EV/FFO N/A
P/B N/A
Growth
20 /100
Declining Rev. growth 0.00%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 2,249.84%
Op. margin 1,826.45%
FCF margin 1,225.52%
Quality
61 /100
Average ROA 451.89%
Asset turnover 0.20x
ROIC 1,654.75%
Debt
52 /100
Moderate Int. coverage -4.31x
Net debt/EBITDA -0.82x
Current ratio 0.55x
Stability
31 /100
Unstable Rev. volatility 0.00%
EPS volatility 4,091.19%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre RGRX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
J. J. Finkelstein
Employees
2
Headquarters
Rockville